Does Insurance Cover GLP-1 Medications for Weight Loss? (2026)

Insurance coverage for GLP-1 weight loss medications is often the largest factor in monthly out-of-pocket cost, and coverage policies vary widely. This guide summarizes publicly reported coverage patterns as of 2026. For specifics about your plan, always call your insurer directly.

The Short Version

• Commercial insurance: Coverage is expanding but inconsistent. Roughly half of large employer plans now cover Wegovy or Zepbound with prior authorization.
• Medicare Part D: Generally does NOT cover GLP-1s for weight loss. Some plans now cover Wegovy for cardiovascular risk reduction in obesity patients with heart disease.
• Medicaid: Varies by state. Some states cover, most don't.
• Diabetes medications (Ozempic, Mounjaro): Much more likely to be covered for diabetic patients. Off-label weight loss use rarely covered.

What Gets Covered and Why

Insurance coverage depends on three things:

1. The medication's FDA label - Is this drug approved for what you're taking it for?
2. Your plan's formulary - Does your specific insurance plan list this drug as covered?
3. Prior authorization - Can your doctor document that you meet the plan's criteria?

On-label use is much easier to get covered:

• Ozempic for diabetes: usually covered
• Mounjaro for diabetes: usually covered
• Wegovy for obesity/weight management: coverage is expanding
• Zepbound for obesity/weight management: coverage is expanding

Off-label use is usually denied:

• Ozempic for weight loss (without diabetes): typically denied
• Mounjaro for weight loss (without diabetes): typically denied

Commercial Insurance (Employer Plans)

As of 2026, the major trends:

• ~55% of large employers offer plans that cover Wegovy and/or Zepbound for weight loss with prior authorization. This is up from ~35% in 2023.
• Prior auth requirements typically include: BMI 30+ (or 27+ with comorbidity), documented weight loss attempts, specific age range (usually 18-65), and sometimes enrollment in a wellness program.
• Annual caps: Some plans limit GLP-1 coverage to a specific dollar amount or duration (e.g., 12-18 months of coverage).
• Step therapy: Some plans require you to try cheaper alternatives (phentermine, Contrave, Saxenda) first.

To check your coverage:

1. Look up your plan's formulary online (search your insurer's website for "formulary" + your plan name)
2. Call the member services number on your insurance card
3. Have your provider submit a prior authorization to get a definitive answer

Medicare

Medicare Part D has been prohibited by law from covering "weight loss drugs" since the 2003 Medicare Modernization Act. This is why Wegovy, Zepbound, and Saxenda weren't covered by Medicare for years.

The 2024 change: When the FDA expanded Wegovy's label to include cardiovascular risk reduction in adults with obesity and established cardiovascular disease, some Part D plans began covering Wegovy for that specific indication. This is NOT the same as covering it for weight loss - your cardiologist or PCP has to document cardiovascular disease and indicate the cardiovascular protection purpose.

What this means practically:

• If you're on Medicare and have obesity + heart disease: your Part D plan may cover Wegovy
• If you're on Medicare and just have obesity: generally still not covered
• If you're on Medicare with diabetes: Ozempic or Mounjaro may be covered for diabetes treatment

Medicaid

Medicaid coverage is set state-by-state. Some broad patterns:

• States that cover some GLP-1s for weight loss: California, Michigan, Pennsylvania, Virginia, and a handful of others (subject to change)
• States that don't cover GLP-1s for weight loss: Most states
• Diabetes coverage: Ozempic and Mounjaro are typically covered for Medicaid patients with type 2 diabetes

Check your state's Medicaid formulary or call the Medicaid member services line in your state.

Manufacturer Savings Programs

Even without insurance coverage, manufacturers offer direct savings:

Wegovy (Novo Nordisk):

• Insured + covered: as low as $0/month with WegovyRx Savings Offer (up to $225 off, $2,700/year max)
• Insured + not covered: $499/month cash through NovoCare Pharmacy
• Not eligible: Medicare, Medicaid, VA patients

Zepbound (Eli Lilly):

• Insured + covered: as low as $25/month with LillyDirect savings
• Cash pay vial: $349-$499/month through LillyDirect
• Not eligible: Medicare, Medicaid, VA patients

Always check current eligibility and benefit amounts directly with the manufacturer - these programs change frequently.

If Coverage Is Denied

Your first denial is not final. Here's what to do:

1. Request the specific reason. Ask for the denial letter. Common reasons: "not medically necessary," "experimental," "step therapy required," "not on formulary."

2. Appeal with documentation. Your provider can submit an appeal with:

   • BMI and weight history
   • Evidence of weight-related conditions (hypertension, diabetes, sleep apnea, cardiovascular disease)
   • Documentation of previous weight loss attempts
   • Medical records supporting medical necessity

3. Consider alternatives if appeals fail:

   • Manufacturer cash-pay program ($499/month)
   • Compounded semaglutide or tirzepatide through telehealth ($150-$350/month)
   • Different GLP-1 that might be covered (if denied for Wegovy, try asking about Zepbound and vice versa)

What to Do Right Now

If you're researching GLP-1 medications and want to understand your coverage:

1. Check your insurance formulary. Search your insurer's website for your plan + "formulary" or "drug list."
2. Call member services. Have them tell you what's covered for weight loss medications specifically, and what prior authorization requirements apply.
3. Ask your provider to run a test prior authorization. Some providers will submit a quick prior auth to see what the insurance will approve before prescribing.
4. Compare providers with different insurance handling. Some telehealth platforms work with insurance (PlushCare, LifeMD, Sequence, Noom Med), others are cash-only (Henry Meds, Mochi Health, Ivim Health). Browse all insurance-accepting providers to filter.

The Bottom Line

Insurance coverage for GLP-1 weight loss medications is better than it was two years ago and still worse than it should be. If you have commercial insurance, check your formulary - you might be covered. If you're on Medicare, coverage is limited unless you have obesity + cardiovascular disease. If you're uninsured, cash-pay through manufacturer programs or compounded telehealth providers is your path.

Pricing and coverage policies change constantly. Always verify current details with your insurance company and provider before committing to a specific medication.